Shane K. Green

Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.

Shan Man, Guido Bocci, Giulio Francia et al. · PubMed · 2002 · 317 citations

Chemoprevention Strategy, Pharmacotherapy, Metronomic Chemotherapy +22

Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.

Giannoula Klement, Ping Huang, Barbara Mayer et al. · PubMed · 2002 · 246 citations

Breast Oncology, Pathology, Pharmacotherapy +20

Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies

Guido Bocci, Shan Man, Shane K. Green et al. · Cancer Research · 2004 · 160 citations

Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy <i>in vitro</i>

Shane K. Green, Giulio Francia, Ciro Isidoro et al. · Molecular Cancer Therapeutics · 2004 · 104 citations · Full text

Cell Adhesion, Immunology, Immunotherapeutics +17

Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer.

Shane K. Green, Mikael C. I. Karlsson, Jeffrey V. Ravetch et al. · PubMed · 2002 · 71 citations

Cell Adhesion, Immunology, Immunotherapy +16